Serous Epithelial Ovarian Cancer: Retrospective Analysis of 260 Cases

Main Article Content

Sedat Akgöl
https://orcid.org/0000-0001-8609-3049
Erhan Aktürk
İpek Yıldız Özaydın
Fatma Ölmez
Sema Karakaş
https://orcid.org/0000-0002-2795-4766
Süleyman Cemil Oğlak
https://orcid.org/0000-0001-7634-3008
Adnan Budak
Ömer Fatih Ölmez
https://orcid.org/0000-0001-7934-7039
Mehmet Şükrü Budak
Özgür Akbayır

Abstract

Objective: To evaluate the outcomes of patients who were followed up and treated for serous epithelial ovarian tumor.


Materials and Methods: This retrospective study included 260 patients who were diagnosed with serous epithelial ovarian cancer, treated and followed up at Kanuni Sultan Suleyman Training and Research Hospital between January 2002 and December 2019.


Results: The mean age of the patients participated in the study was 53.4±11.6 years. Of the patients, 79.7% had advance stage and 82.4% had grade 3 tumors. The rate of complete or optimal surgery was 88.2%, while the rate of suboptimal surgery was 11.2%. While 82% of the patients received adjuvant chemotherapy, 15.7% received neoadjuvant chemotherapy. Of the patients, 80.2% had a Ca 125 value higher than 35. Despite primary cytoreductive surgery and platinum-based adjuvant chemotherapy, the recurrence rate was 66.2%, and the PFS and OS rates were 34.7±41.0 and 50.5±40.0 months, respectively.


Conclusion: The majority of serous epithelial ovarian cancers are diagnosed at an advanced stage. Despite primary situ reductive surgery and subsequent platinum-based chemotherapy, the recurrence rates are quite high.

Article Details

How to Cite
1.
Akgöl S, Aktürk E, Yıldız Özaydın İpek, Ölmez F, Karakaş S, Oğlak SC, Budak A, Ölmez Ömer F, Budak M Şükrü, Akbayır Özgür. Serous Epithelial Ovarian Cancer: Retrospective Analysis of 260 Cases. Aegean J Obstet Gynecol [Internet]. 2021 Apr. 3 [cited 2021 Jun. 14];3(1):19-21. Available from: https://aejog.com/index.php/aejog/article/view/83
Section
Original Article

Most read articles by the same author(s)